← Company directoryNYSE American · SEC EDGAR
Impact Biomedical Inc.
IBOA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
SHARE PRICE · INDICATIVE——
A recent price could not be verified. Check the exchange before trading.
ANALYSIS ROUTE
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Dates connected to this company
Confirmed events from the FinRatex financial calendar, linked to their named sources.
Impact Biomedical 1-for-12.62 reverse stock split
Impact Biomedical's 1-for-12.62 reverse stock split becomes effective at 12:01 AM ET on September 23, with IBO shares due to trade on a split-adjusted basis from that day's NYSE American open. The company also corrected the proposed Zoar merger exchange ratio from 1-for-4 to one Zoar share for each IBO share held after the split. Merger completion is not assured.
Impact Biomedical ↗More NYSE American records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
EADAllspring Income Opportunities FundNYSE American · NYSE American→ERCAllspring Multi-Sector Income FundNYSE American · NYSE American→ERHAllspring Utilities and High Income FundNYSE American · NYSE American→PHXE.PPhoenix Energy One, LLC Series A Preferred SharesNYSE American · NYSE American→OPTTOcean Power Technologies, Inc.NYSE American · SEC→
DATA STATUS
Open official filings ↗Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.